Semaglutide in the Real World: Attitudes of the Population.

IF 1.8 Q3 PHARMACOLOGY & PHARMACY
Pharmacy Pub Date : 2025-09-04 DOI:10.3390/pharmacy13050128
Doris Rušić, Toni Durdov, Ivona Jadrijević, Ana Šešelja Perišin, Dario Leskur, Joško Božić, Mila Marie Klusmeier, Josipa Bukić
{"title":"Semaglutide in the Real World: Attitudes of the Population.","authors":"Doris Rušić, Toni Durdov, Ivona Jadrijević, Ana Šešelja Perišin, Dario Leskur, Joško Božić, Mila Marie Klusmeier, Josipa Bukić","doi":"10.3390/pharmacy13050128","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Clinical experience with semaglutide in patients with type 2 diabetes mellitus shows that its benefits extend far beyond glucose regulation. This study examines whether this drug is indeed popular among the Croatian population and explores whether factors such as gender or proximity to the healthcare sector influence its potential use, attitudes toward weight loss, and knowledge regarding its application and possible adverse effects.</p><p><strong>Methods: </strong>This was a cross-sectional population study. In this study we focused on the brand name Ozempic<sup>®</sup> for semaglutide as it is the most commonly searched term for semaglutide.</p><p><strong>Results: </strong>The study included 290 participants, most of who were women (<i>N</i> = 243, 83.8%). As many as 214 (73.8%) people stated they had heard of Ozempic<sup>®</sup>; however, there was no significant difference in whether people had heard of Ozempic<sup>®</sup> if they had type 2 diabetes mellitus (<i>p</i> = 0.415). In total, 23.4% of people stated they knew someone who took Ozempic<sup>®</sup>. Women were significantly more likely to feel pressure about their appearance than men, with 51.1% of men reporting no pressure at all compared to only 39.9% of women (<i>p</i> = 0.015). A majority of participants agreed that social media strongly affects perception on the use of medications for weight loss (73.8%). Individuals with a family member in the healthcare field were significantly more informed about the possible adverse reactions of semaglutide compared to those without such a connection. Among participants without a healthcare professional in the family, 75.0% reported being unaware of potential adverse effects, compared to 47.9% of those with a family member in healthcare. Moreover, participants with a healthcare professional in the family were more likely to know the correct route of administration for Ozempic<sup>®</sup> (68.1% vs. 54.6%, <i>p</i> = 0.025); Conclusions: The results of this study show that three-quarters of people had heard of Ozempic<sup>®</sup>, regardless of whether they had an indication for its use or not. In addition, the results indicate that although both men and women share satisfaction with their bodies, women feel more pressured by societal expectations related to their appearance.</p>","PeriodicalId":30544,"journal":{"name":"Pharmacy","volume":"13 5","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12452689/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/pharmacy13050128","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Clinical experience with semaglutide in patients with type 2 diabetes mellitus shows that its benefits extend far beyond glucose regulation. This study examines whether this drug is indeed popular among the Croatian population and explores whether factors such as gender or proximity to the healthcare sector influence its potential use, attitudes toward weight loss, and knowledge regarding its application and possible adverse effects.

Methods: This was a cross-sectional population study. In this study we focused on the brand name Ozempic® for semaglutide as it is the most commonly searched term for semaglutide.

Results: The study included 290 participants, most of who were women (N = 243, 83.8%). As many as 214 (73.8%) people stated they had heard of Ozempic®; however, there was no significant difference in whether people had heard of Ozempic® if they had type 2 diabetes mellitus (p = 0.415). In total, 23.4% of people stated they knew someone who took Ozempic®. Women were significantly more likely to feel pressure about their appearance than men, with 51.1% of men reporting no pressure at all compared to only 39.9% of women (p = 0.015). A majority of participants agreed that social media strongly affects perception on the use of medications for weight loss (73.8%). Individuals with a family member in the healthcare field were significantly more informed about the possible adverse reactions of semaglutide compared to those without such a connection. Among participants without a healthcare professional in the family, 75.0% reported being unaware of potential adverse effects, compared to 47.9% of those with a family member in healthcare. Moreover, participants with a healthcare professional in the family were more likely to know the correct route of administration for Ozempic® (68.1% vs. 54.6%, p = 0.025); Conclusions: The results of this study show that three-quarters of people had heard of Ozempic®, regardless of whether they had an indication for its use or not. In addition, the results indicate that although both men and women share satisfaction with their bodies, women feel more pressured by societal expectations related to their appearance.

Semaglutide在现实世界:人口的态度。
背景:在2型糖尿病患者中使用西马鲁肽的临床经验表明,它的益处远远超出了血糖调节。本研究考察了这种药物是否确实在克罗地亚人口中流行,并探讨了性别或接近医疗保健部门等因素是否会影响其潜在用途、对减肥的态度以及有关其应用和可能的不良影响的知识。方法:这是一项横断面人群研究。在这项研究中,我们关注的是semaglutide的品牌名称Ozempic®,因为它是semaglutide最常搜索的术语。结果:研究纳入290名参与者,其中大多数为女性(N = 243, 83.8%)。多达214人(73.8%)表示他们听说过Ozempic®;然而,患有2型糖尿病的人是否听说过Ozempic®没有显著差异(p = 0.415)。总共有23.4%的人表示他们认识服用Ozempic®的人。女性明显比男性更容易对自己的外表感到压力,51.1%的男性表示完全没有压力,而女性只有39.9% (p = 0.015)。大多数参与者同意社交媒体强烈影响人们对使用减肥药物的看法(73.8%)。有家庭成员在医疗保健领域的个人比没有这种联系的人更了解西马鲁肽可能的不良反应。在家庭中没有医疗保健专业人员的参与者中,75.0%的人报告不知道潜在的不良影响,而有医疗保健家庭成员的参与者中这一比例为47.9%。此外,家庭中有医疗保健专业人员的参与者更有可能知道Ozempic®的正确给药途径(68.1%对54.6%,p = 0.025);结论:本研究结果表明,四分之三的人听说过Ozempic®,无论他们是否有使用适应症。此外,研究结果还表明,尽管男性和女性都对自己的身材感到满意,但女性对自己的外表感到的社会期望压力更大。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmacy
Pharmacy PHARMACOLOGY & PHARMACY-
自引率
9.10%
发文量
141
审稿时长
11 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信